Topical Application of Latanoprost in Diabetic Retinopathy.

Trial Profile

Topical Application of Latanoprost in Diabetic Retinopathy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Dec 2014

At a glance

  • Drugs Latanoprost (Primary)
  • Indications Diabetic retinopathy
  • Focus Therapeutic Use
  • Acronyms Latano-2
  • Most Recent Events

    • 11 Sep 2012 Lead trial centre added as reported by ClinicalTrials.gov.
    • 11 Sep 2012 Planned end date changed from 1 May 2013 to 1 Dec 2014 as reported by ClinicalTrials.gov.
    • 16 Nov 2011 Additional trial acronym Latano-2 identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top